volume 24, issue 1, P8-24 2016
DOI: 10.1108/mbr-06-2015-0025
View full text
|
|
Share
Andrew M. Brajcich, Daniel L. Friesner, Tim J. Schibik

Abstract: Purpose The purpose of this study is to empirically identify incentives that drive resource shifting by US pharmaceutical firms to comparatively low-tax jurisdictions. Design/methodology/approach Using a panel of publicly listed companies, we investigate whether resource shifting is facilitated by two underlying factors. First, we examine whether pharmaceutical manufacturers whose intangible assets are disproportionately held as intellectual property are more or less likely to shift resources to jurisdictio…

expand abstract